Quest Diagnostics (DGX) Operating Expenses (2009 - 2026)

Quest Diagnostics has reported Operating Expenses for 18 years, with the latest figure at $2.6 billion in Q2 2026.

• Quarterly Operating Expenses rose 11.24% year-over-year to $2.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.9 billion (up 9.76% YoY) and the FY2025 annual result came in at $9.5 billion, up 11.18% from the prior year.
• Operating Expenses rose to $2.6 billion in Q2 2026 per DGX's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $2.6 billion in Q2 2026 and troughed at $2.0 billion in Q3 2023.
• A 5-year average of $2.2 billion and a median of $2.1 billion in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses slipped 8.05% in 2023, then increased 13.76% in 2025.
• Over 5 years, Operating Expenses stood at $2.2 billion in 2022, then fell by 8.05% to $2.0 billion in 2023, then climbed by 11.83% to $2.3 billion in 2024, then rose by 7.08% to $2.4 billion in 2025, then gained by 6.78% to $2.6 billion in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $2.6 billion, $2.5 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.